GLP-1 RA use is associated with a greater but moderate reduction in HbA 1c and lower risk of DKA when compared with SGLT2i therapy
Key Benefits of Weight Loss Injections Weight loss injections are an effective and non-surgical option for those looking to shed stubborn pounds and improve metabolic function
Why GLP-1 medications cause constipation in the first place Understanding the mechanism matters
Dandona P, Mathieu C, Phillip M, Hansen L, Griffen SC, Tschope D, et al
Whether you want IV hydration, energy support, or immune support, we can set up right in your home
These medications reduce hyperglycemia (Hb1Ac reduction of 0.8 1.4%) through the inhibition of glucose reabsorption in the proximal convoluted tubule of the kidney and the resulting increase in glycosuria ( In light of this evidence, these therapies have opened a new paradigm not only for the management of altered glucose metabolism in T2D but also in consideration of their pleiotropic effects ( Emerging data indicate that the growth hormone (GH)/insulin-like growth factor-1 (IGF-1) axis may play a role in either mediating the metabolic and neuroendocrine effect of these drugs or responding to the profound body modifications fostered by GLP-1RAs and SGLT-2is